IL13RA2 is being clinically tested as a possible cancer vaccination and CAR-T treatment target as a glioma-specific cell-surface epitope. Functionally, there are two categories of IL-13 receptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback